Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Oxygen dosing during surgery: a key to better lung recovery?

NCT ID NCT06746181

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 95 adults having abdominal surgery to see if different oxygen levels during the procedure affect how well the lungs work afterward. Doctors measured lung stiffness and checked for complications like collapsed lungs or low oxygen. The goal is to find the best oxygen setting to keep lungs healthy during surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
different inspired oxygen concentrations (FiO2)
What this could lead to
If successful, this could help doctors choose the best oxygen level during surgery to improve lung function and reduce complications like collapsed lungs.
What could go wrong
This is a small, single-center study with only 95 participants. Results may not apply to all patients or surgeries, and the benefit may be small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

95 people

The number who actually took part.

Started

Apr 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 64 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ASA physical status classification: I or II. * Adults aged 18 to 64 years, regardless of gender. * BMI between 18 kg/m² and 25 kg/m². * Patients undergoing elective abdominal surgery under general anesthesia. * Patients with estimated operating time ≥1.5h and intraoperative bleeding ≤500ml. * Patients who have provided written informed consent after understanding the study purpose, procedures, and potential risks. Exclusion Criteria: * Previous thoracic surgery. * Chest X-ray or CT suggestive of pneumothorax or alveoli. * Lung disease: chronic bronchitis, asthma, moderate to severe obstructive ventilatory dysfunction. * Preoperative pulse oxygen saturation (SpO2) \<90% on breathing air or SpO2 \<95% on oxygen. * Contraindications to lung reanimation: high intracranial pressure, hypovolemic shock, right heart failure. * Severe heart disease (New York Heart Association, NYHA class III or IV. * Acute coronary syndrome or sustained ventricular tachyarrhythmia). * Participation in other interventional studies or refusal of enrollment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pulmonary atelectasis, postoperative are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pulmonary Atelectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Northern Jiangsu People's Hospital

    Yangzhou, Jiangsu, 225001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.